← All investors

Medison

1 portfolio company · 1 on the map · $379.5M raised · 1 cities

Portfolio map

1 Medison portfolio company on the map.

Portfolio companies

Keros Therapeutics
Lexington
Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.
Biotechnology Research$379.5MEst. 2016

Portfolio map

1 Medison portfolio company on the map.

Medison portfolio | CleraMap